Chicago, IL, United States of America

Tyson J Moyer

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tyson J Moyer. Retrieved from https://idiyas.com/inventor/tyson-j-moyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tyson J Moyer in Cardiovascular Therapy

Introduction

Tyson J Moyer is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of cardiovascular medicine through his innovative research and patented inventions. His work focuses on targeted therapies that aim to improve patient outcomes in cardiovascular health.

Latest Patents

Tyson J Moyer holds a patent for "Targeted therapy for the prevention of restenosis in the cardiovascular system." This patent encompasses compositions and methods for targeted drug delivery designed to prevent restenosis, a common complication in cardiovascular procedures. Specifically, the invention includes nanoscale delivery vehicles for drugs that inhibit proliferation and neointimal hyperplasia, thereby enhancing the effectiveness of cardiovascular treatments.

Career Highlights

Moyer is affiliated with Northwestern University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to revolutionize how cardiovascular diseases are treated, particularly in preventing complications that arise after surgical interventions.

Collaborations

Tyson J Moyer has worked alongside notable colleagues, including Melina R Kibbe and Samuel I Stupp. These collaborations have further enriched his research and contributed to advancements in targeted therapies for cardiovascular health.

Conclusion

Tyson J Moyer's innovative approach to cardiovascular therapy exemplifies the impact of targeted drug delivery systems in modern medicine. His contributions are paving the way for improved treatment options and better patient outcomes in the field of cardiovascular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…